Oryzon Genomics SA (ORYZF)

3.36 0.00 (0.00%) USD  |  OTCM  |  Aug 24, 16:00
More

Oryzon Genomics Revenue Estimates for Current Quarter

Revenue Estimates for Current Quarter Chart

View Revenue Estimates for Current Quarter for ORYZF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Current Quarter Chart
Start Trial

Historical Revenue Estimates for Current Quarter Data

View and export this data back to . Start Trial.
Date Value

Revenue Estimates for Current Quarter Range, Past 5 Years

View Revenue Estimates for Current Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Current Quarter Benchmarks

View Revenue Estimates for Current Quarter Benchmarks
Start Trial
Pharma Mar SA Upgrade
Grifols SA Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
Alkermes Plc Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade